Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...

Better donor-recipient heart size matching with echocardiographic LVM improves post-transplant survival, especially in ...

Discover a recent study, the RAIDER trial, in which 82% of patients received dose-escalated radiotherapy and experienced ...

Study identifies NMLR as a predictor of 5-year mortality in COPD patients, paving the way for personalised care and improved survival outcomes.